The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis. [PDF]
HH Tsai, KR Lees, CW Howden, JL Reid
openalex +1 more source
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono +3 more
wiley +1 more source
Pharmacodynamic correlates of modified absorption: studies with lormetazepam. [PDF]
D. M. Pierce +3 more
openalex +1 more source
Objective Biomarkers with clear contexts of use are important tools for amyotrophic lateral sclerosis (ALS) therapy development. Understanding their longitudinal trajectory in the untreated state is key to their use as potential markers of pharmacodynamic response.
Oleksandr Dergai +16 more
wiley +1 more source
Comparison of single‐dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero‐ order release rates. [PDF]
SJ Warrington +4 more
openalex +1 more source
Peptide/Antibody–Drug Conjugates for Therapeutic Applications in Inflammatory Disease
Peptide/antibody–drug conjugates (PADCs) combine ligand specificity and cleavable linkers to deliver drugs precisely to disease sites with minimal toxicity. While current approvals focus on oncology, this review examines their untapped potential in inflammatory diseases, detailing mechanisms of targeted delivery and highlighting advances that position ...
Yeongji Jang +5 more
wiley +1 more source
A Study of the Pharmacodynamics of Oxytetracycline in the Chicken
W D Black
openalex +1 more source
Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects [PDF]
Ah‐Ng Tony Kong +6 more
openalex +1 more source
The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol. [PDF]
MS Lennard +5 more
openalex +1 more source

